Editorial: Novel insights in RNA modifications: From basic to translational research

Huilin Huang; Chengqi Yi; Pengxu Qian; Hengyou Weng; Jianjun Chen

doi:10.3389/fcell.2023.1155993

Editorial: Novel insights in RNA modifications: From basic to translational research

Front Cell Dev Biol. 2023 Feb 22:11:1155993. doi: 10.3389/fcell.2023.1155993. eCollection 2023.

Authors

Huilin Huang¹, Chengqi Yi^{2

3

4}, Pengxu Qian^{5

6}, Hengyou Weng^{7

8}, Jianjun Chen^{9

10}

Affiliations

¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
² State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China.
³ Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
⁴ Department of Chemical Biology, Synthetic and Functional Biomolecules Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
⁵ Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁶ Liangzhu Laboratory, Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Zhejiang University Medical Center, Institute of Hematology, Zhejiang University, Hangzhou, China.
⁷ Guangzhou Laboratory, Guangzhou, China.
⁸ State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
⁹ Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, United States.
¹⁰ Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.

No abstract available

Keywords: M6A; RNA editing; RNA vaccine; biomarker; cancer; development; epitranscriptome.

Publication types

Editorial

Grants and funding

This work was supported by the National Key Research and Development Program of China (2020YFA0112403 to HW, 2019YFA0110900 and 2019YFA0802200 to CY, 2022YFA1103500 and 2018YFA0109300 to PQ), the National Natural Science Foundation of China (82173058 to HH, 82270168 to HW, 21825701 and 92153303 to CY, 82222003, 92268117 and 82161138028 to PQ), the U.S. National Institutes of Health (NIH) grants (R01 CA243386 and R01 CA271497 to JC), Guangdong Basic and Applied Basic Research Foundation (2021A1515010425 to HH), the Zhejiang Provincial Natural Science Foundation of China (LR19H080001 to PQ), the Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang (2020R01006 to PQ) and the Guangdong Research Program (2021ZT09Y233 to HW).